Stela McLachlan
Overview
Explore the profile of Stela McLachlan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
5707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suarez-Ortegon M, McLachlan S, Fernandez-Real J, Wilson J, Wild S
Eur J Clin Invest
. 2024 Sep;
54(12):e14312.
PMID: 39239983
Background: There are conflicting results among studies on the association between serum ferritin (SF) and metabolic syndrome (MetS), and by groups of sex/menopausal status. To date, there are no studies...
2.
Blayney M, Reed M, Masterson J, Anand A, Bouamrane M, Fleuriot J, et al.
BMJ Med
. 2024 Aug;
3(1):e000731.
PMID: 39184567
Abstract: Objectives: To describe the effect of multimorbidity on adverse patient centred outcomes in people attending emergency department. Design: Population based cohort study. Setting: Emergency departments in NHS Lothian in...
3.
Baschant U, Fuqua B, Ledesma-Colunga M, Vulpe C, McLachlan S, Hofbauer L, et al.
Bone
. 2024 Apr;
184:117092.
PMID: 38575048
Purpose: Bone is susceptible to fluctuations in iron homeostasis, as both iron deficiency and overload are linked to poor bone strength in humans. In mice, however, inconsistent results have been...
4.
Suarez-Ortegon M, Prats-Puig A, Bassols J, Carreras-Badosa G, McLachlan S, Wild S, et al.
Diabetes Res Clin Pract
. 2023 Jun;
202:110795.
PMID: 37355100
Aim: We aimed to evaluate associations between serum ferritin and transferrin and variables related to the metabolic syndrome (MetS) in children. Methods: Cross-sectional and longitudinal study in prepubertal children (n ...
5.
Huang Z, Klaric L, Krasauskaite J, McLachlan S, Strachan M, Wilson J, et al.
Cardiovasc Diabetol
. 2022 Apr;
21(1):62.
PMID: 35477395
Background: Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is...
6.
Suarez-Ortegon M, McLachlan S, Fernandez-Real J, Tuomainen T, Aregbesola A, Wild S
Cardiovasc Diabetol
. 2022 Feb;
21(1):26.
PMID: 35172838
Background: Iron stores, estimated as ferritin levels, and type 2 diabetes (T2D) have been associated previously, while findings regarding coronary heart disease (CHD) and cerebrovascular disease (CEVD) are still inconclusive....
7.
Sluiman A, McLachlan S, Forster R, Strachan M, Deary I, Price J
Diabetologia
. 2021 Dec;
65(3):467-476.
PMID: 34932135
Aims/hypothesis: We aimed to determine the longitudinal association of circulating markers of systemic inflammation with subsequent long-term cognitive change in older people with type 2 diabetes. Methods: The Edinburgh Type...
8.
Grecian S, McLachlan S, Fallowfield J, Hayes P, Guha I, Morling J, et al.
Obes Sci Pract
. 2021 Oct;
7(5):497-508.
PMID: 34631129
Background: Type 2 diabetes (T2D) is associated with increased risk of progression to cirrhosis and hepatocellular carcinoma (HCC) in people with chronic liver diseases, particularly non-alcoholic fatty liver disease (NAFLD)....
9.
van Zuydam N, Stiby A, Abdalla M, Austin E, Dahlstrom E, McLachlan S, et al.
Circ Genom Precis Med
. 2021 Oct;
14(5):e002862.
PMID: 34601942
Background: Peripheral artery disease (PAD) affects >200 million people worldwide and is associated with high mortality and morbidity. We sought to identify genomic variants associated with PAD overall and in...
10.
Deaths in critical care and hospice-prevalence, trends, influences: a national decedent cohort study
Mayes J, McLachlan S, Carduff E, McPeake J, Boyd K, Pattison N, et al.
BMJ Support Palliat Care
. 2021 Aug;
PMID: 34380665
Objectives: End-of-life and bereavement care support services differ in critical care and inpatient hospice settings. There are limited population-level data comparing deaths in these two locations. We aimed to compare...